litigation

News

Is J&J approaching the end of its talc litigation hangover?

Johnson & Johnson has made a $5.5bn bid to finally bring more than 15 years of litigation over the safety of its talcum powder products to a close.

News

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.

News

Colorado's pathfinder medicine price-cap move stalls

A federal judge in the US has sided with Amgen in a dispute over a price cap imposed by the state of Colorado on blockbuster immunology drug Enbrel.

News

SCOTUS backs generic firm Hikma in skinny label dispute

SCOTUS has delivered its ruling in a closely watched 'skinny label' lawsuit between Amarin and Hikma, which could have far-reaching implications.

News

Novo Nordisk fight with KBP Bio will go to arbitration

Singapore court keeps an asset freeze on KBP Bio, saying the merits of its dispute with Novo Nordisk over a licensing deal must go to arbitration.

News

Jury finds Takeda liable for $885m in pay-for-delay lawsuit

Takeda is on the hook for $885m damages – which could rise to $2.5bn – in a suit claiming it paid a rival to delay the launch of a generic competitor.

Is J&J approaching the end of its talc litigation hangover?

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Colorado's pathfinder medicine price-cap move stalls

SCOTUS backs generic firm Hikma in skinny label dispute

Novo Nordisk fight with KBP Bio will go to arbitration

Jury finds Takeda liable for $885m in pay-for-delay lawsuit

CHMP backs Novo's haemophilia A drug Frehemgo

Discover a new era of healthcare panel engagement: Grounded ...

litigation

Editor's Picks